Piramal Pharma submits analyst meet intimation

21 Feb 2024 Evaluate
Piramal Pharma has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst or Institutional Investor Meetings with the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

150.60 -6.00 (-3.83%)
23-Jan-2026 13:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1633.65
Dr. Reddys Lab 1237.55
Cipla 1305.30
Zydus Lifesciences 880.35
Lupin 2143.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×